Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     

  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     

  • Bitcoin CAD

    87,421.10
    +3,081.05 (+3.65%)
     

  • CMC Crypto 200

    1,368.29
    +55.66 (+4.24%)
     

  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Stocks in play: Isracann Biosciences Inc

Baystreet.ca
·1 min read

Announces that, further to the Company’s news releases dated February 23, 2022 and March 28, 2022, it has closed its acquisition of Praesidio Health Inc. Pursuant to the definitive agreement dated March 24, 2022 with Praesidio and the shareholders of Praesidio, the Company acquired all of the issued and outstanding shares in the capital of Praesidio for aggregate consideration of C$4,000,000 in common shares in the capital of the Company. Praesidio will operate as a wholly-owned subsidiary of the Company. Isracann Biosciences Inc shares C.IPOT are trading unchanged at $0.07.

Read: